Shortage reports
Actual shortage:
283 (9%)
Anticipated shortage:
1 (0%)
Avoided shortage:
10 (0%)
Resolved:
2953 (91%)
3247
Discontinuation Reports
To be discontinued:
2 (0%)
Discontinued:
410 (94%)
Reversed:
23 (5%)
435
483 (13%)
16 (6%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-HALOPERIDOL | 1MG | TABLET | Resolved | 2020-10-01 | 2020-10-22 | 125470 |
| TEVA-HALOPERIDOL | 1MG | TABLET | Resolved | 2021-06-03 | 2021-06-10 | 140375 |
| TEVA-HYDROCHLOROTHIAZIDE | 25MG | TABLET | Resolved | 2025-05-08 | 2025-06-19 | 256908 |
| TEVA-HYDROCHLOROTHIAZIDE | 25MG | TABLET | Actual shortage | 2025-10-23 | 2025-12-04 | 270227 |
| TEVA-HYDROCHLOROTHIAZIDE | 50MG | TABLET | Resolved | 2020-04-10 | 2020-05-08 | 111868 |
| TEVA-HYDROCHLOROTHIAZIDE | 25MG | TABLET | Resolved | 2021-06-10 | 2021-07-15 | 140690 |
| TEVA-HYDROCHLOROTHIAZIDE | 50MG | TABLET | Actual shortage | 2025-10-30 | 2025-10-30 | 270672 |
| TEVA-HYDROCHLOROTHIAZIDE | 25MG | TABLET | Resolved | 2020-04-02 | 2020-05-08 | 110697 |
| TEVA-HYDROCHLOROTHIAZIDE | 25MG | TABLET | Resolved | 2022-12-01 | 2023-01-26 | 176758 |
| TEVA-HYDROCHLOROTHIAZIDE | 25MG | TABLET | Resolved | 2020-04-02 | 2020-05-08 | 110700 |
| TEVA-HYDROMORPHONE | 4MG | TABLET | Resolved | 2017-03-13 | 2020-02-13 | 1006 |
| TEVA-HYDROMORPHONE | 8MG | TABLET | Resolved | 2017-03-13 | 2020-02-13 | 1009 |
| TEVA-HYDROMORPHONE | 1MG | TABLET | Resolved | 2017-03-13 | 2020-02-13 | 997 |
| TEVA-HYDROMORPHONE | 2MG | TABLET | Resolved | 2017-03-13 | 2020-02-13 | 1001 |
| TEVA-IMATINIB | 100MG | TABLET | Resolved | 2022-11-14 | 2023-04-28 | 174613 |
| TEVA-IMATINIB | 100MG | TABLET | Resolved | 2020-09-24 | 2020-10-01 | 124974 |
| TEVA-IMATINIB | 100MG | TABLET | Resolved | 2019-08-22 | 2019-11-14 | 92148 |
| TEVA-IMATINIB | 100MG | TABLET | Resolved | 2021-07-15 | 2021-08-13 | 142625 |
| TEVA-IMATINIB | 400MG | TABLET | Resolved | 2021-02-18 | 2021-03-11 | 134334 |
| TEVA-IMATINIB | 100MG | TABLET | Resolved | 2025-05-02 | 2025-05-08 | 256471 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT OLMESARTAN | 20MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117497 |
| ACT OLMESARTAN HCT | 40MG 25MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117519 |
| ACT OLMESARTAN HCT | 20MG 12.5MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117513 |
| ACT OLMESARTAN HCT | 40MG 12.5MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117516 |
| ACT OXYCODONE CR | 5MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65328 |
| ACT OXYCODONE CR | 80MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63992 |
| ACT OXYCODONE CR | 40MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63989 |
| ACT OXYCODONE CR | 20MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63986 |
| ACT OXYCODONE CR | 10MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63983 |
| ACT PROGESTERONE INJECTION | 50MG | SOLUTION | Discontinued | 2025-05-28 | 2025-05-28 | 258417 |
| ACT PROGESTERONE INJECTION | 50MG | SOLUTION | Discontinued | 2025-04-29 | 2025-04-29 | 256082 |
| ACT QUETIAPINE | 300MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258643 |
| ACT QUETIAPINE | 200MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258648 |
| ACT RANITIDINE | 300MG | TABLET | Discontinued | 2020-05-14 | 2020-05-14 | 115082 |
| ACT RANITIDINE | 150MG | TABLET | Discontinued | 2020-05-14 | 2020-05-14 | 115079 |
| ACT RIZATRIPTAN | 10MG | TABLET | Discontinued | 2021-07-22 | 2021-07-22 | 142912 |
| ACT TADALAFIL | Discontinued | 2018-10-22 | 2018-10-22 | 65284 | ||
| ACT TADALAFIL | Discontinued | 2018-10-22 | 2018-10-22 | 65289 | ||
| ACT VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65298 |
| ACT VENLAFAXINE XR | 75.0MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65295 |